Drug Updates

COVID-19 EUA Testing Requirement Change

March 17, 2023 • By the U.S. Food & Drug Administration Center for Drug Evaluation & Research

FDA Approves Sarilumab for the Treatment of Adults with Glucocorticoid-Resistant PMR

March 14, 2023 • By Michele B. Kaufman, PharmD, BCGP

Glucocorticoid Use May Result in Loss of Bone Mineral Density

March 8, 2023 • By Michele B. Kaufman, PharmD, BCGP

ACR Releases New Vaccination Guideline

March 6, 2023 • By Ruth Jessen Hickman, MD

Sarilumab Approved for the Treatment of Adults with Glucocorticoid-Resistant PMR

March 3, 2023 • By Keri Losavio

Cardiovascular Safety with RA Treatments

March 2, 2023 • By Michele B. Kaufman, PharmD, BCGP

Glucocorticoids May Decrease White Matter Integrity & Change Gray Matter Volume

February 27, 2023 • By Samantha C. Shapiro, MD

FDA Approves Abaloparatide to Treat Men with Osteoporosis & a High Risk of Fracture

February 15, 2023 • By Michele B. Kaufman, PharmD, BCGP

FDA Revokes Emergency Use Authorization for Evusheld

February 2, 2023 • By From the College

First Biosimilar to Adalimumab Enters the U.S. Market After Years of Legal Battles

January 31, 2023 • By Michele B. Kaufman, PharmD, BCGP

1
2
3
…
123
Next Page »